AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

JPMORGAN MID CAP INV TRUST PLC

Declaration of Voting Results & Voting Rights Announcements Apr 30, 2019

5177_dva_2019-04-30_5af930d8-2d5e-4b47-865d-b1a7b1a362f0.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 6402X

JPMorgan Mid Cap Invest Trust PLC

30 April 2019

STOCK EXCHANGE ANNOUNCEMENT

VOTING RIGHTS AND CAPITAL

JPMORGAN MID CAP INVESTMENT TRUST PLC

(the 'Company')

Legal Entity Identifier: 549300QED7IGEP4UFN49

Information disclosed in accordance with DTR 5.6

In conformity with the Transparency Directive, the Company would like to notify the market of the following:

As at 30th April 2019, the Company's issued share capital consists of 25,398,080 Ordinary 25 pence shares with voting rights. The Company holds 1,680,400 Ordinary shares in Treasury.

Therefore, as at 30th April 2019, the total number of voting rights in JPMorgan Mid Cap Investment Trust plc is 23,717,680.

The above figure (23,717,680) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, JPMorgan Mid Cap Investment Trust plc under the FCA's Disclosure Guidance and Transparency Rules.

30th April 2019  

For further information, please contact:

Alison Vincent

For and on behalf of

JPMorgan Funds Limited - Secretary

020 7742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

TVRQBLFXKZFFBBD

Talk to a Data Expert

Have a question? We'll get back to you promptly.